Mark Kaye - 24 Feb 2025 Form 4 Insider Report for CONMED Corp (CNMD)

Role
Director
Signature
/s/ Thomas Fistek for Mark Kaye by Power of Attorney
Issuer symbol
CNMD
Transactions as of
24 Feb 2025
Net transactions value
$0
Form type
4
Filing time
26 Feb 2025, 09:33:49 UTC
Previous filing
04 Oct 2024
Next filing
05 Mar 2025
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CNMD Options To Purchase Common Stock Award $0 +1,846 $0.000000 1,846 24 Feb 2025 Common Stock 1,846 $61.97 Direct F1
transaction CNMD RSUs (Restricted Stock Units) Award $0 +152 $0.000000 152 24 Feb 2025 Common Stock 152 $0.000000 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock options were granted under the Company's 2020 Amended and Restated Non-Employee Director Equity Compensation Plan and generally vest 100% after a one year period.
F2 Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2020 Amended and Restated Non-Employee Director Equity Compensation Plan, with the RSUs generally vesting 100% after a one year period.